secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2026-09-01T18:13:08+00:00
Accession:  0001472375-26-000214
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma discloses delinquent Q1/Q2 2026 10-Qs; 10-K filed late
-----------------------------------------------------------------------

- 2025 Form 10-K filed after deadline; Q1 and Q2 2026 10-Qs not yet filed and delinquent.
- Company did not file Form 12b-25 notifications for the outstanding quarterly reports.
- Delay attributed to additional accounting, reconciliation, and review work related to 10-K and quarterly statements.
- Management working to complete and file outstanding reports as soon as practicable; no expected change to operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237526000214/0001472375-26-000214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237526000214/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-26-000214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer